| Literature DB >> 35631527 |
Ivo Laidmäe1,2, Alar Aints1, Raivo Uibo1,3.
Abstract
The incidence of type I diabetes has been increasing worldwide at an annual rate of approximately 3%. One of the strategies to treat type I diabetes is islet transplantation, in which damaged β-cells are replaced with new islets. To improve β-cells' expansion and pseudoislet formation, studies are focusing on using extracellular-matrix-resembling substrates. We evaluated the potential of salmon fibrinogen and chitosan electrospun scaffold as cell substrate for cultivating MIN-6 cells. The morphology of cells, insulin secretion and gene expression was evaluated and compared with other substrates (nanofibrous scaffold, microporous scaffold and tissue culture polystyrene). We found that all tested 3D conditions favored the pseudoislet formation of MIN-6 cells. The insulin secretion of MIN-6 cells after stimulation with high-glucose media shows approximately a 9-fold increase compared to the control group when a fibrinogen/chitosan-based electrospun scaffold was used for cultivation. The differences in insulin secretion were corroborated by differences in gene expression. The differences in insulin secretion could probably be attributed to the differences in the mechanical and/or chemical nature of the tested substrates.Entities:
Keywords: 3D cell culturing; electrospinning; insulin secretion; pancreatic islet β-cells; salmon fibrinogen
Year: 2022 PMID: 35631527 PMCID: PMC9144899 DOI: 10.3390/pharmaceutics14050941
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
PCR primers used for gene expression analysis.
| Genes | Sequences |
|---|---|
| tspan7_Mm_5′974 | TCTGCCTTTCAGCCCACGTC |
| tspan7_Mm_3′1167 | CTGAAGCCTCCCCTACTACATGC |
| cldn7_Mm_5′612 | GCGGGCGACAACATCATCACA |
| cldn7_Mm_3′784 | ATCGTGGCGACAAACATGGCTA |
| chgb_Mm_5′223 | CCCTATCCAAGTCCAGTGTTCCAA |
| chgb_Mm_3′434 | CACTTCTCATTGCCTACCTTCGTC |
| scg5_Mm_5′260 | CTCACCAGGCCATGAATCTTGTTG |
| scg5_Mm_3′489 | ACTGGAATTCTCGGCTGAACTCT |
| scg3_Mm_5′202 | CTCTCCCTTCCCGCACCCAG |
| scg3_Mm_3′344 | CAGTATCCAAGAGCCGGTCCA |
| ceacam1_Mm_5′529 | GCCCTTCCTCCAAGTCACCAAC |
| ceacam1_Mm_3′730 | CGCTGACTGGATTCGAGATTTCACAC |
| ins1_Mm_5′268 | AACCCACCCAGGCTTTTGTCA |
| ins1_Mm_3′464 | ACTGATCCACAATGCCACGCTTC |
| ins2_Mm_5′139 | CCCCACCCAGGCTTTTGTCA |
| ins2_Mm_3′340 | ACTGATCTACAATGCCACGCTTC |
| actb_Mm_5′367 | GCACCACACCTTCTACAATGAGC |
| actb_Mm_3′558 | CTCCGGAGTCCATCACAATGC |
| cdh1_Mm_5′930 | CAGAGTTTACCCAGCCGGTCT |
| cdh1_Mm_3′1149 | ATGTAGGGTAACTCTCTCGGTCCA |
| itgb1_Mm_5′532 | CAGCCAAGTGACATAGAGAATCCCA |
| itgb1_Mm_3′840 | GCCAAAGCCAATGCGGAAGTCT |
| itga6_Mm_5′1080 | AGAGACATGAAGTCCGCGCATC |
| itga6_Mm_3′1282 | ACGAATCGGCTTCACATTACTCC |
Figure 1SEM and fiber diameter distributions of chitosan (CS, left column) and fibrinogen/chitosan (FCS, right column) scaffolds.
Key fiber parameters of electrospun scaffolds.
| CS Scaffold | FCS Scaffold | |
|---|---|---|
| Mean diameter (nm ± | 144.1 ± | 525.9 ± |
| Median diameter (nm) | 115.0 | 192.8 |
| Minimum diameter (nm) | 67.4 | 76.9 |
| Maximum diameter (nm) | 391.7 | 3743.4 |
| Mid-range value (nm ± | 229.6 ± | 1910.2 ± |
Figure 2Formation of pseudoislets on 3D scaffolds. White arrows indicate poorly visible pseudoislet structures in Alvetex scaffold.
Figure 3Stereomicroscope images of pseudoislets on 3D scaffolds at day 37.
Figure 4Normalized induced insulin secretion relative to TCP in supernatants of MIN-6 cells cultured on different scaffolds, after 25 mM glucose challenge. Insulin values were normalized to the cell counts in each group. * p ≤ 0.005.
Figure 5Gene expression differences after 10 days of culture (n = 2) as measured by rt-PCR and displayed as –ΔΔCt (±SD group average). * p < 0.05.